Omalizumab
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4774 publications
Real world efficacy of dupilumab in switchers versus biological naive CRSwNP patients.
Journal: Rhinology
Published: June 23, 2026
In brief: Dupilumab (Dupixent) for allergic fungal rhinosinusitis.
Journal: The Medical letter on drugs and therapeutics
Published: June 15, 2026
Dupilumab for severe asthma complicated with chronic spontaneous urticaria refractory to omalizumab and mepolizumab: a case report
Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
Published: June 03, 2026
STAT3 gene-related hyper-IgE syndrome complicated by pulmonary aspergillosis: a case report
Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
Published: June 03, 2026
Chronic Spontaneous Urticaria Combined Atopic Dermatitis/Other Atopic Comorbidities: Clinical Characteristics, Therapeutic Response to Omalizumab, and Drug Survival.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: May 29, 2026
A case of eosinophilic dermatosis of hematologic malignancy treated with omalizumab.
Journal: JAAD case reports
Published: May 25, 2026
Documentation of biological treatment in asthma
Journal: Pneumologie (Stuttgart, Germany)
Published: May 18, 2026
Novelties in the pragmatic management of anaphylaxis in pediatric age.
Journal: European journal of pediatrics
Published: May 11, 2026
Expert consensus on the diagnosis and treatment of allergic bronchopulmonary aspergillosis with integrated traditional Chinese and western medicine (2026 edition)
Journal: Zhonghua yi xue za zhi
Published: May 08, 2026
The medical management of chronic rhinosinusitis with nasal polyps and aspirin-exacerbated respiratory in the biologic age.
Journal: Allergy and asthma proceedings
Published: April 29, 2026
Last Updated: 06/30/2026